SCHEMBL9054212

SCHEMBL9054212

CNC(=N)c1ccc([C@@H]2C[C@H](CC(=O)C(N)CC(=O)O)ON2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8505472 0.72 ITGB3 (0.46) —
SCHEMBL7438736 0.71 ITGB3 (0.53) —
SCHEMBL7371138 0.68 ITGB3 (0.46) —
SCHEMBL8128142 0.67 ITGB3 (0.30) —
SCHEMBL8114641 0.65 ITGB3 (0.32) —
SCHEMBL7367239 0.64 ITGB3 (0.39) —
SCHEMBL7378740 0.63 ITGB3 (0.38) —
SCHEMBL7372714 0.63 KCNH2 (0.37) —
SCHEMBL7375252 0.63 ITGB3 (0.45) —
SCHEMBL7452928 0.62 ITGB3 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0730589-A1 ISOXAZOLINE COMPOUNDS USEFUL AS FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 — — EP claimed
Send feedback